When the analysis was performed in all DM-ILD, low CD3+CD8+ cell count was independent predictor of death (HR 8.6) even after adjusting for anti-MDA5 and other clinical characteristics, and the HR was much higher than that of anti-MDA5 (HR 2.08) (Table 6). The gene discussed is CD8A; the disease is dermatomyositis.